1. Home
  2. CCIX vs TKNO Comparison

CCIX vs TKNO Comparison

Compare CCIX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCIX
  • TKNO
  • Stock Information
  • Founded
  • CCIX 2023
  • TKNO 1996
  • Country
  • CCIX United States
  • TKNO United States
  • Employees
  • CCIX N/A
  • TKNO N/A
  • Industry
  • CCIX
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • CCIX
  • TKNO Health Care
  • Exchange
  • CCIX Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • CCIX 367.7M
  • TKNO 390.7M
  • IPO Year
  • CCIX 2024
  • TKNO 2021
  • Fundamental
  • Price
  • CCIX $10.29
  • TKNO $7.73
  • Analyst Decision
  • CCIX
  • TKNO Buy
  • Analyst Count
  • CCIX 0
  • TKNO 2
  • Target Price
  • CCIX N/A
  • TKNO $5.00
  • AVG Volume (30 Days)
  • CCIX 101.1K
  • TKNO 206.5K
  • Earning Date
  • CCIX 01-01-0001
  • TKNO 11-07-2024
  • Dividend Yield
  • CCIX N/A
  • TKNO N/A
  • EPS Growth
  • CCIX N/A
  • TKNO N/A
  • EPS
  • CCIX N/A
  • TKNO N/A
  • Revenue
  • CCIX N/A
  • TKNO $36,347,000.00
  • Revenue This Year
  • CCIX N/A
  • TKNO $3.47
  • Revenue Next Year
  • CCIX N/A
  • TKNO $12.07
  • P/E Ratio
  • CCIX N/A
  • TKNO N/A
  • Revenue Growth
  • CCIX N/A
  • TKNO N/A
  • 52 Week Low
  • CCIX $10.00
  • TKNO $1.16
  • 52 Week High
  • CCIX $11.17
  • TKNO $8.91
  • Technical
  • Relative Strength Index (RSI)
  • CCIX N/A
  • TKNO 51.60
  • Support Level
  • CCIX N/A
  • TKNO $7.00
  • Resistance Level
  • CCIX N/A
  • TKNO $8.89
  • Average True Range (ATR)
  • CCIX 0.00
  • TKNO 0.74
  • MACD
  • CCIX 0.00
  • TKNO -0.09
  • Stochastic Oscillator
  • CCIX 0.00
  • TKNO 38.24

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Share on Social Networks: